Calcitonin

Administration
  • Type:
  • Dosage Forms:
  • Routes of Administration: SC/IM, nasal
  • Common Trade Names:

Adult Dosing

Pediatric Dosing

Safety/efficacy not established

Special Populations

Pregnancy Rating
  • C

Lactation risk

    Renal Dosing
    • Adult:
    • Pediatric:

    Hepatic Dosing
    • Adult:
    • Pediatric:

    Contraindications
    • Allergy to class/drug

    Adverse Reactions

    Serious
    • Malignancy risk increased in longterm use

    Common
    • Rhinitis, epistaxis (intranasal)
    • Arthralgia, back pain
    • Injection site reaction
    • Nausea, abdominal pain, decreased appetite
    • Headache
    • Flushing
    • Allergic reaction
    • Edema of feet
    • Eye pain
    • Subjective fever
    • Nocturia
    • Salty taste

    Pharmacology
    • Half-life: 43min[1]
    • Metabolism: Renal
    • Excretion: Urinary

    Mechanism of Action
    • Inhibits osteoclastic bone resorption, decreases serum calcium, and increases renal excretion of phosphate, calcium, sodium magnesium and potassium by decreasing tubular reabsorption[2]


    Comments


    See Also

    References
    1. https://reference.medscape.com/drug/fortical-miacalcin-calcitonin-salmon-342816#10
    2. https://reference.medscape.com/drug/fortical-miacalcin-calcitonin-salmon-342816#10
    This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.